Activity from announced rounds
Playground Global is a deep-technology firm whose official portfolio identifies Infinimmune and PicoJool and which Mesa names as financing lead.
Mesa develops miniature quantum sensors. PicoJool develops optical computing links, while RegCell develops reprogrammed immune-cell therapies. These investments concern different physical and biological systems.
RegCell is developing cell therapies for autoimmune disease by epigenetically reprogramming pathogenic conventional T cells into stable regulatory T cells, aiming to restore immune tolerance without gene engineering; its platform is advancing toward clinical development.
Develops human-derived antibody therapeutics for atopic dermatitis and inflammatory disease